Cargando…
Immunotherapy in endometrial cancer - an evolving therapeutic paradigm
Endometrial cancer is the only gynecologic malignancy with a rising incidence and mortality. While cure is routinely achieved with surgery alone or in combination with adjuvant pelvic radiotherapy when disease is confined to the uterus, patients with metastatic or recurrent disease exhibit limited r...
Autores principales: | Longoria, Teresa C., Eskander, Ramez N. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4881063/ https://www.ncbi.nlm.nih.gov/pubmed/27231571 http://dx.doi.org/10.1186/s40661-015-0020-3 |
Ejemplares similares
-
Erratum to: Immunotherapy in endometrial cancer - an evolving therapeutic paradigm
por: Longoria, Teresa C., et al.
Publicado: (2016) -
Immunotherapy as a treatment strategy in advanced stage and recurrent
endometrial cancer: review of current phase III immunotherapy clinical
trials
por: Eskander, Ramez N., et al.
Publicado: (2021) -
Metastatic small cell neuroendocrine carcinoma of the cervix treated with the PD-1 inhibitor, nivolumab: a case report
por: Paraghamian, Sarah E., et al.
Publicado: (2017) -
EZH2 inhibition in ARID1A mutated clear cell and endometrioid ovarian and endometrioid endometrial cancers
por: Alldredge, Jill K., et al.
Publicado: (2017) -
Epithelial cell-adhesion molecule-directed trifunctional antibody immunotherapy for symptom management of advanced ovarian cancer
por: Eskander, Ramez N, et al.
Publicado: (2013)